GB9501127D0 - Tablet - Google Patents

Tablet

Info

Publication number
GB9501127D0
GB9501127D0 GBGB9501127.6A GB9501127A GB9501127D0 GB 9501127 D0 GB9501127 D0 GB 9501127D0 GB 9501127 A GB9501127 A GB 9501127A GB 9501127 D0 GB9501127 D0 GB 9501127D0
Authority
GB
United Kingdom
Prior art keywords
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9501127.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9501127(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GBGB9501127.6A priority Critical patent/GB9501127D0/en
Publication of GB9501127D0 publication Critical patent/GB9501127D0/en
Priority to CN96192661A priority patent/CN1131026C/zh
Priority to ZA96448A priority patent/ZA96448B/xx
Priority to MYPI96000222A priority patent/MY126346A/en
Priority to ES96900626T priority patent/ES2145425T3/es
Priority to SK964-97A priority patent/SK282030B6/sk
Priority to US08/875,172 priority patent/US5879706A/en
Priority to CNB2003101029136A priority patent/CN1313081C/zh
Priority to TR97/00657T priority patent/TR199700657T1/xx
Priority to BR9606769A priority patent/BR9606769A/pt
Priority to CA002210891A priority patent/CA2210891C/en
Priority to NZ298846A priority patent/NZ298846A/en
Priority to PCT/GB1996/000111 priority patent/WO1996022082A1/en
Priority to APAP/P/1997/001057A priority patent/AP666A/en
Priority to CZ0229297A priority patent/CZ296514B6/cs
Priority to EA199700123A priority patent/EA000276B1/ru
Priority to EP96900626A priority patent/EP0806943B1/en
Priority to DK96900626T priority patent/DK0806943T3/da
Priority to DE69607146T priority patent/DE69607146T2/de
Priority to SI9630193T priority patent/SI0806943T1/xx
Priority to IL11683096A priority patent/IL116830A/xx
Priority to GEAP19963844A priority patent/GEP20022752B/en
Priority to IN100MA1996 priority patent/IN181318B/en
Priority to RO97-01333A priority patent/RO118175B1/ro
Priority to EE9700352A priority patent/EE03336B1/xx
Priority to UA97084269A priority patent/UA68325C2/uk
Priority to AT96900626T priority patent/ATE190483T1/de
Priority to HU9801872A priority patent/HU226131B1/hu
Priority to PT96900626T priority patent/PT806943E/pt
Priority to KR1019970704915A priority patent/KR100412298B1/ko
Priority to HK98101962.5A priority patent/HK1002851B/en
Priority to AU44534/96A priority patent/AU710823B2/en
Priority to JP52212696A priority patent/JP3350055B2/ja
Priority to OA70052A priority patent/OA10500A/en
Priority to MXPA/A/1997/005459A priority patent/MXPA97005459A/xx
Priority to PL96321361A priority patent/PL185307B1/pl
Priority to NO19973327A priority patent/NO311488B1/no
Priority to FI973062A priority patent/FI119722B/fi
Priority to BG101831A priority patent/BG63187B1/bg
Priority to UY25774A priority patent/UY25774A1/es
Priority to UY25778A priority patent/UY25778A1/es
Priority to GR20000401364T priority patent/GR3033677T3/el
Priority to CY0000042A priority patent/CY2182B1/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9501127.6A 1995-01-20 1995-01-20 Tablet Pending GB9501127D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet
AU44534/96A AU710823B2 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
JP52212696A JP3350055B2 (ja) 1995-01-20 1996-01-19 コロイド状二酸化ケイ素を含むバラシクロビール錠剤
SI9630193T SI0806943T1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
GEAP19963844A GEP20022752B (en) 1995-01-20 1996-01-19 Valaciclovir Tablets Containing Colloidal Silicon Dioxide
MYPI96000222A MY126346A (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
ES96900626T ES2145425T3 (es) 1995-01-20 1996-01-19 Comprimidos de valaciclovir que contienen dioxido de silicio coloidal.
SK964-97A SK282030B6 (sk) 1995-01-20 1996-01-19 Tablety s obsahom valacyklovírusu a spôsob ich výroby
US08/875,172 US5879706A (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
CNB2003101029136A CN1313081C (zh) 1995-01-20 1996-01-19 含有胶体二氧化硅的缬无环鸟苷片剂
TR97/00657T TR199700657T1 (xx) 1995-01-20 1996-01-19 Kolloidal silikon dioksit i�eren valasiklovir tabletleri.
BR9606769A BR9606769A (pt) 1995-01-20 1996-01-19 Tablete e processos para tratamento de uma infecção de vírus do herpes em um humano e para preparação do tablete
CA002210891A CA2210891C (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
NZ298846A NZ298846A (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
PCT/GB1996/000111 WO1996022082A1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
APAP/P/1997/001057A AP666A (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide.
CZ0229297A CZ296514B6 (cs) 1995-01-20 1996-01-19 Tableta
EA199700123A EA000276B1 (ru) 1995-01-20 1996-01-19 Таблетки валацикловира, содержащие коллоидный диоксид кремния
EP96900626A EP0806943B1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
DK96900626T DK0806943T3 (da) 1995-01-20 1996-01-19 Valaciclovir-tabletter indeholdende kolloidt siliciumdioxid
RO97-01333A RO118175B1 (ro) 1995-01-20 1996-01-19 Tableta acoperita cu un film pentru utilizare terapeutica si procedeu de preparare al acesteia
CN96192661A CN1131026C (zh) 1995-01-20 1996-01-19 含有胶体二氧化硅的缬无环鸟苷片剂
IL11683096A IL116830A (en) 1995-01-20 1996-01-19 Tablets comprising valaciclovir their preparation and use
IN100MA1996 IN181318B (enExample) 1995-01-20 1996-01-19
DE69607146T DE69607146T2 (de) 1995-01-20 1996-01-19 Valaciclovir tabletten enthaltend kolloidales silizium dioxid
ZA96448A ZA96448B (en) 1995-01-20 1996-01-19 Tablet
EE9700352A EE03336B1 (et) 1995-01-20 1996-01-19 Kolloidset ränidioksiidi sisaldavad valatsükloviiri tabletid
UA97084269A UA68325C2 (en) 1995-01-20 1996-01-19 Valaciclovir tablet (variants), method for manufacture (variants) and method for treatment
AT96900626T ATE190483T1 (de) 1995-01-20 1996-01-19 Valaciclovir tabletten enthaltend kolloidales silizium dioxid
HU9801872A HU226131B1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide and process for producing them
PT96900626T PT806943E (pt) 1995-01-20 1996-01-19 Comprimidos de valaciclovir contendo dioxido de silicio coloidal
KR1019970704915A KR100412298B1 (ko) 1995-01-20 1996-01-19 콜로이드이산화규소를함유하는발라시클로비르정제
HK98101962.5A HK1002851B (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide
OA70052A OA10500A (en) 1995-01-20 1997-07-16 Valaciclovir tablets containing colloidal silicon dioxide
FI973062A FI119722B (fi) 1995-01-20 1997-07-18 Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia
MXPA/A/1997/005459A MXPA97005459A (en) 1995-01-20 1997-07-18 Valaciclovir tablets containing silicon dioxide color
PL96321361A PL185307B1 (pl) 1995-01-20 1997-07-18 Tabletka zawierająca walacyklowir lub jego sól i koloidalny dwutlenek krzemu i sposób wytwarzania tabletki zawierającej walacyklowir lub jego sól i koloidalny dwutlenek krzemu
NO19973327A NO311488B1 (no) 1995-01-20 1997-07-18 Valaciclovir-tabletter inneholdende kolloidalt silisiumdioksyd, anvendelse av valaciclovir for fremstilling avtablett, samt fremgangsmåte for fremstilling av nevnte tablett
BG101831A BG63187B1 (bg) 1995-01-20 1997-08-14 Валацикловирови таблетки, съдържащи колиодален силициев диоксид
UY25774A UY25774A1 (es) 1995-01-20 1999-10-28 Tabletas de valaciclovir que contienen dioxido de silicio coloidal
UY25778A UY25778A1 (es) 1995-01-20 1999-10-29 Proceso para preparar tabletas de valaciclovir que contiene dioxido de silicio coloidal
GR20000401364T GR3033677T3 (en) 1995-01-20 2000-06-14 Valaciclovir tablets containing colloidal silicon dioxide
CY0000042A CY2182B1 (en) 1995-01-20 2000-08-23 Valaciclovir tablets containing colloidal silicon dioxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet

Publications (1)

Publication Number Publication Date
GB9501127D0 true GB9501127D0 (en) 1995-03-08

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9501127.6A Pending GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet

Country Status (38)

Country Link
US (1) US5879706A (enExample)
EP (1) EP0806943B1 (enExample)
JP (1) JP3350055B2 (enExample)
KR (1) KR100412298B1 (enExample)
CN (2) CN1313081C (enExample)
AP (1) AP666A (enExample)
AT (1) ATE190483T1 (enExample)
AU (1) AU710823B2 (enExample)
BG (1) BG63187B1 (enExample)
BR (1) BR9606769A (enExample)
CA (1) CA2210891C (enExample)
CY (1) CY2182B1 (enExample)
CZ (1) CZ296514B6 (enExample)
DE (1) DE69607146T2 (enExample)
DK (1) DK0806943T3 (enExample)
EA (1) EA000276B1 (enExample)
EE (1) EE03336B1 (enExample)
ES (1) ES2145425T3 (enExample)
FI (1) FI119722B (enExample)
GB (1) GB9501127D0 (enExample)
GE (1) GEP20022752B (enExample)
GR (1) GR3033677T3 (enExample)
HU (1) HU226131B1 (enExample)
IL (1) IL116830A (enExample)
IN (1) IN181318B (enExample)
MY (1) MY126346A (enExample)
NO (1) NO311488B1 (enExample)
NZ (1) NZ298846A (enExample)
OA (1) OA10500A (enExample)
PL (1) PL185307B1 (enExample)
PT (1) PT806943E (enExample)
RO (1) RO118175B1 (enExample)
SK (1) SK282030B6 (enExample)
TR (1) TR199700657T1 (enExample)
UA (1) UA68325C2 (enExample)
UY (2) UY25774A1 (enExample)
WO (1) WO1996022082A1 (enExample)
ZA (1) ZA96448B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
ZA97400B (en) * 1996-01-19 1997-11-13 Glaxo Group Ltd Valaciclovir.
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
UA75135C2 (en) * 2001-05-01 2006-03-15 Pfizer Prod Inc Dry granulation method for manufacturing pharmaceutical composition containing tetrahydronaphthalene-2-ol derivative and low dosage tablet compositions
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
JP2005511612A (ja) * 2001-11-05 2005-04-28 グラクソ　グループ　リミテッド 塩酸バラシクロビルの無水結晶形
JP2005508993A (ja) * 2001-11-14 2005-04-07 テバ ファーマシューティカル インダストリーズ リミティド バラシクロビルの合成及び精製
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1517678A2 (en) * 2002-06-24 2005-03-30 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20050070711A1 (en) * 2002-10-16 2005-03-31 Igor Lifshitz Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US7786302B2 (en) * 2003-05-30 2010-08-31 Eczacibasi-Zentiva Kimyasal Urunler Sanayi Ve Ticaret A.S. Crystalline forms of valacyclovir hydrochloride
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1663182B2 (en) 2003-09-12 2019-11-20 Amgen Inc. RAPID DISSOLUTION FORMULATION OF CINACALCET HCl
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1541133B1 (en) * 2003-12-09 2005-08-10 Helm AG Pharmaceutical formulation of valaciclovir
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
KR101335932B1 (ko) 2005-03-07 2013-12-04 바이엘 헬스케어 엘엘씨 암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
US7846937B2 (en) * 2005-05-25 2010-12-07 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
US20090312439A1 (en) * 2006-05-10 2009-12-17 Ralph Hofmann Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions
PL2037887T3 (pl) * 2006-05-31 2011-03-31 Vertex Pharma Doustne preparaty o kontrolowanym uwalnianiu inhibitora enzymu konwertującego interleukinę 1 beta
US20090291136A1 (en) * 2006-07-11 2009-11-26 Lek Pharmaceuticals D.D. Multiple Unit Tablets
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US8513261B2 (en) * 2009-03-13 2013-08-20 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
US20230201234A1 (en) * 2020-06-01 2023-06-29 Shilpa Medicare Ltd Fast dispersible pharmaceutical composition comprising capecitabine
CN116528853B (zh) * 2020-12-01 2026-03-20 信达生物科技有限公司 包含1-(3-氰基-1-异丙基-吲哚-5-基)吡唑-4-甲酸的口服制剂及其制备方法
WO2024047094A1 (en) * 2022-08-31 2024-03-07 Astrazeneca Ab Pharmaceutical formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
ZA96448B (en) 1996-08-07
EP0806943B1 (en) 2000-03-15
AP666A (en) 1998-08-24
EA199700123A1 (ru) 1997-12-30
HUP9801872A2 (hu) 1999-10-28
KR19980701524A (ko) 1998-05-15
PT806943E (pt) 2000-08-31
EP0806943A1 (en) 1997-11-19
MX9705459A (es) 1997-10-31
DE69607146D1 (de) 2000-04-20
IL116830A (en) 2000-02-29
WO1996022082A1 (en) 1996-07-25
CN1313081C (zh) 2007-05-02
CZ296514B6 (cs) 2006-03-15
FI973062L (fi) 1997-09-18
AP9701057A0 (en) 1997-10-31
KR100412298B1 (ko) 2004-04-21
PL321361A1 (en) 1997-12-08
IN181318B (enExample) 1998-05-09
OA10500A (en) 2002-04-10
BG101831A (en) 1998-04-30
CN1494898A (zh) 2004-05-12
BR9606769A (pt) 1997-12-30
EA000276B1 (ru) 1999-02-25
GR3033677T3 (en) 2000-10-31
HU226131B1 (en) 2008-05-28
FI119722B (fi) 2009-02-27
NO973327D0 (no) 1997-07-18
FI973062A0 (fi) 1997-07-18
CZ229297A3 (cs) 1998-02-18
NO973327L (no) 1997-09-16
AU4453496A (en) 1996-08-07
AU710823B2 (en) 1999-09-30
UY25778A1 (es) 2000-08-21
CY2182B1 (en) 2002-08-23
EE03336B1 (et) 2001-02-15
DE69607146T2 (de) 2000-09-21
SK282030B6 (sk) 2001-10-08
CN1179100A (zh) 1998-04-15
MY126346A (en) 2006-09-29
UY25774A1 (es) 2000-10-31
HK1002851A1 (en) 1998-09-25
NZ298846A (en) 1998-06-26
DK0806943T3 (da) 2000-07-24
IL116830A0 (en) 1996-05-14
BG63187B1 (bg) 2001-06-29
JP3350055B2 (ja) 2002-11-25
ATE190483T1 (de) 2000-04-15
HUP9801872A3 (en) 2001-02-28
US5879706A (en) 1999-03-09
CA2210891C (en) 2009-05-19
SK96497A3 (en) 1998-01-14
JPH10512564A (ja) 1998-12-02
RO118175B1 (ro) 2003-03-28
GEP20022752B (en) 2002-08-26
CA2210891A1 (en) 1996-07-25
CN1131026C (zh) 2003-12-17
TR199700657T1 (xx) 1998-02-21
UA68325C2 (en) 2004-08-16
ES2145425T3 (es) 2000-07-01
NO311488B1 (no) 2001-12-03
PL185307B1 (pl) 2003-04-30

Similar Documents

Publication Publication Date Title
GB9501127D0 (en) Tablet
IL123614A0 (en) Chewable tablet
AU132520S (en) Tablet
AU128017S (en) Pharmaceutical tablet
AU133610S (en) Tablet
AU129056S (en) Pharmaceutical tablet
EP0852208A4 (en) TABLET CONTAINER
GB9518465D0 (en) Pharmaceuticals
AP9600802A0 (en) Libricant
CA77348S (en) Tablet
GB9525706D0 (en) Tablet dispencer
CA76097S (en) Can
AU1105P (en) DALESE Metrosideros excelsus
GB9517038D0 (en) Pharmaceuticals
GB9513768D0 (en) Pharmaceuticals
GB9507708D0 (en) Pharmaceuticals
GB9508237D0 (en) Pharmaceuticals
GB9526703D0 (en) Pharmaceuticals
GB9525938D0 (en) Pharmaceuticals
GB9522579D0 (en) Pharmaceuticals
GB9520678D0 (en) Pharmaceuticals
GB9520676D0 (en) Pharmaceuticals
GB9517308D0 (en) Pharmaceuticals
GB9505548D0 (en) Pharmaceuticals
GB9506663D0 (en) Pharmaceuticals